Investigator Slapped With FDA Warning for Enrolling Ineligible Patients in Trial

Clinical Trials Advisor
The FDA has warned a clinical investigator that half of the patients in her study are ineligible to participate based on the study protocol.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00